…
Vitalhub Corp., together with its subsidiaries, provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. The company offers patient flow, operational visibility, and patient journey optimization solutions for hospital and integrated health environments, including SHREWD, Intouch with Health, Strata Health, MedCurrent, Beautiful Information, My Pathway, BookWise Solutions, Jayex Acute, MCAP, and Oculys. It also provides electronic healthcare record, case management, care coordination, and optimization solutions to inpatient/outpatient care providers, long-term care, and community and social services focused organizations, such as TREAT, CaseWORKS, clarity, Community Data Solutions, S12, B Care, DOCit, hicom, Clarity Healthcare Solutions, and Pirouette. In addition, the company offers a workforce automation and compliance suite that integrates and centralizes workforce and compliance data, which includes Hicom, Premier IT, and BookWise. Vitalhub Corp. was founded in 2010 and is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Vitalhub Corp provides software for healthcare organizations, focusing on electronic health records, care coordination and analytics used by community health providers, home care and long-term care agencies. Long-term growth drivers include aging populations, ongoing digitalization of health services and recurring SaaS/managed-service contracts, and investors may view its niche market exposure and subscription-based revenue as supportive of more predictable cash flows.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 5.90M | 5.90M | 5.33M | 1.31M | -1.61M |
| Net income | 6.11M | 3.00M | 4.55M | 1.21M | -1.95M |
| Selling general administrative | 35.39M | 17.80M | 12.92M | 9.70M | 6.80M |
| Selling and marketing expenses | - | 6.77M | 5.88M | 4.28M | 3.61M |
| Gross profit | 76.51M | 55.49M | 37.83M | 32.94M | 19.43M |
| Reconciled depreciation | 11.08M | 5.96M | 4.98M | 3.87M | 2.68M |
| Ebit | 12.17M | 5.94M | 6.86M | 4.66M | 0.32M |
| Ebitda | 23.25M | 11.90M | 11.84M | 8.54M | 3.00M |
| Depreciation and amortization | 11.08M | 5.96M | 4.98M | 3.87M | 2.68M |
| Operating income | 12.17M | 9.74M | 6.86M | 4.66M | 0.32M |
| Other operating expenses | 96.80M | 58.85M | 45.65M | 35.31M | 24.37M |
| Interest expense | 0.07M | 0.04M | 0.07M | 0.07M | 0.08M |
| Tax provision | -0.21M | 2.90M | 0.78M | 0.09M | 0.33M |
| Interest income | 2.42M | 1.91M | 0.49M | 0.07M | 0.03M |
| Net interest income | 2.35M | 1.91M | 0.42M | -0.07M | -0.05M |
| Income tax expense | -0.21M | 2.90M | 0.78M | 0.09M | 0.33M |
| Total revenue | 108.97M | 68.59M | 52.51M | 39.97M | 24.66M |
| Total operating expenses | 64.34M | 45.75M | 30.97M | 28.28M | 19.13M |
| Cost of revenue | 32.46M | 13.10M | 14.68M | 7.03M | 5.24M |
| Total other income expense net | -6.27M | -3.85M | -1.53M | -3.29M | -1.86M |
| Net income from continuing ops | 6.11M | 3.00M | 4.55M | 1.21M | -1.95M |
| Net income applicable to common shares | - | 3.00M | - | 1.21M | -1.95M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 352.71M | 207.19M | 118.78M | 106.19M | 72.77M |
| Intangible assets | 92.82M | 51.59M | 28.90M | 30.85M | 19.59M |
| Other current assets | 3.66M | - | 0.96M | - | - |
| Total liab | 86.78M | 62.33M | 36.88M | 30.79M | 17.95M |
| Total stockholder equity | 265.93M | 144.86M | 81.91M | 75.40M | 54.82M |
| Other current liab | 13.08M | 0.45M | 7.34M | 2.80M | 11.24M |
| Common stock | 248.86M | - | 79.96M | 79.73M | 61.14M |
| Capital stock | 248.86M | 134.33M | 79.96M | 79.73M | 61.14M |
| Retained earnings | 5.67M | -0.45M | -3.44M | -8.44M | -9.65M |
| Other liab | - | - | - | 6.46M | 2.69M |
| Good will | 109.09M | 76.88M | 44.86M | 43.34M | 29.32M |
| Cash | 57.63M | 56.57M | 33.48M | 17.45M | 16.39M |
| Total current liabilities | 60.58M | 44.35M | 29.07M | 23.82M | 14.73M |
| Current deferred revenue | 38.68M | - | 19.29M | - | - |
| Net debt | -55.12M | - | -32.94M | - | - |
| Short term debt | 0.53M | - | 0.41M | 0.00M | 0.00M |
| Short long term debt | - | - | - | - | 0.03M |
| Short long term debt total | 2.51M | - | 0.54M | - | - |
| Other stockholder equity | - | - | - | 4.11M | 3.34M |
| Property plant equipment | - | - | - | 1.43M | 1.24M |
| Total current assets | 145.66M | 75.24M | 43.91M | 30.57M | 22.62M |
| Net tangible assets | - | - | - | 1.21M | 5.92M |
| Short term investments | 61.55M | - | - | - | - |
| Net receivables | 22.75M | 15.13M | 9.29M | 11.41M | 5.56M |
| Long term debt | - | - | - | 0.00M | 0.00M |
| Inventory | 0.06M | 0.24M | 0.17M | 0.70M | 0.20M |
| Accounts payable | 8.28M | 6.11M | 2.03M | 2.12M | 1.81M |
| Accumulated other comprehensive income | 11.40M | - | 5.39M | - | - |
| Non currrent assets other | 1.10M | - | 28.93M | - | - |
| Non current assets total | 207.05M | 131.94M | 74.88M | 75.62M | 50.15M |
| Capital lease obligations | 2.51M | 0.61M | 0.54M | 0.88M | 0.76M |
| Long term debt total | - | - | - | 0.51M | 0.52M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -61.55M | -31.39M | -4.15M | -21.84M | -10.06M |
| Change to liabilities | - | - | - | 2.21M | -0.15M |
| Total cashflows from investing activities | -111.11M | -31.39M | - | -21.84M | -21.84M |
| Net borrowings | -0.60M | -0.37M | - | -0.52M | -0.37M |
| Total cash from financing activities | 104.59M | 39.09M | -0.29M | 16.40M | 3.17M |
| Change to operating activities | - | - | - | - | -0.54M |
| Net income | 6.11M | 3.00M | 4.55M | 1.21M | -1.95M |
| Change in cash | 1.05M | 23.09M | 16.03M | 1.06M | -7.00M |
| Begin period cash flow | 56.57M | 33.48M | 17.45M | 16.39M | 23.39M |
| End period cash flow | 57.63M | 56.57M | 33.48M | 17.45M | 16.39M |
| Total cash from operating activities | 8.32M | 15.13M | 20.47M | 6.12M | -0.05M |
| Issuance of capital stock | 103.01M | 37.51M | 0.00M | 16.30M | 0.00M |
| Depreciation | 11.08M | 5.96M | 4.98M | 3.87M | 2.68M |
| Other cashflows from investing activities | 1.23M | -2.09M | - | -1.52M | -0.42M |
| Change to inventory | 0.18M | -0.07M | 0.53M | -0.50M | 0.25M |
| Change to account receivables | 10.14M | -3.99M | 2.40M | -2.04M | -1.89M |
| Sale purchase of stock | - | 39.45M | -0.04M | -0.22M | 3.54M |
| Other cashflows from financing activities | -0.60M | 1.94M | 0.40M | 10.84M | 3.54M |
| Change to netincome | - | - | - | - | 1.36M |
| Capital expenditures | 0.42M | 0.88M | 0.29M | 0.30M | 0.26M |
| Change in working capital | -8.27M | 3.57M | 9.29M | -1.00M | -2.14M |
| Stock based compensation | 2.65M | 2.34M | 1.16M | 1.14M | 1.72M |
| Other non cash items | 2.52M | 0.25M | 7.72M | 0.74M | 0.08M |
| Free cash flow | 7.90M | 14.24M | 20.18M | 5.83M | -0.31M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VHI Vitalhub Corp |
0.25 3.21% |
8.04 | 81.40 | 40.65 | 4.72 | 1.94 | 3.65 | 23.34 |
| AIAI NetraMark Holdings Inc. |
0.01 1.82% |
0.56 | - | - | 513.40 | 71.64 | 504.87 | - |
Vitalhub Corp., together with its subsidiaries, provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. The company offers patient flow, operational visibility, and patient journey optimization solutions for hospital and integrated health environments, including SHREWD, Intouch with Health, Strata Health, MedCurrent, Beautiful Information, My Pathway, BookWise Solutions, Jayex Acute, MCAP, and Oculys. It also provides electronic healthcare record, case management, care coordination, and optimization solutions to inpatient/outpatient care providers, long-term care, and community and social services focused organizations, such as TREAT, CaseWORKS, clarity, Community Data Solutions, S12, B Care, DOCit, hicom, Clarity Healthcare Solutions, and Pirouette. In addition, the company offers a workforce automation and compliance suite that integrates and centralizes workforce and compliance data, which includes Hicom, Premier IT, and BookWise. Vitalhub Corp. was founded in 2010 and is headquartered in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel Matlow | Pres, CEO & Director | 1963 |
| Mr. Brian Goffenberg C.A., CPA, CA | CFO & Exec. VP | NA |
| Mr. Niels Tofting | Exec. VP of Bus. Devel. & Marketing | NA |
| Mr. Robert Lazar | Exec. VP of Professional Services & Customer Care | NA |
| Mr. Vijit Coomara | Exec. VP of Product Devel. | NA |
| Patrick Mazza | Exec. VP of Performance & Operations | NA |
| Graham Farrell | Investor Relations Officer | NA |
| Mr. Andre Vandenberk | Chief Innovations Officer | 1961 |
| Mr. Daniel Matlow | President, CEO & Director | 1963 |
| Mr. Brian Goffenberg C.A., CPA, CA | CFO & Executive VP | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.